Nektar Therapeutics | Zysk Brutto Na Sprzedaży





Zysk Brutto Na Sprzedaży Zmiana Data
Agios Pharmaceuticals USD 11.2M 448K 2025-09
ALKERMES USD 265.83M 8.06M 2025-09
Amgen USD 6.48B 307M 2025-09
Baxter International USD 950M 194M 2025-09
BioCryst Pharmaceuticals USD -88.88M 202.74M 2024-12
Biogen USD 1.65B 34.6M 2025-12
Bristol-Myers Squibb USD 8.79B 110M 2025-09
Cara Therapeutics USD 2.57M 1.11M 2025-03
Cipla INR 41.64B 6.31B 2025-12
Dr.Reddys Laboratories INR 51.37B 629M 2025-12
Eisai JPY 168.85B 17.02B 2025-12
Eli Lilly USD 14.59B 1.48B 2025-09
Esperion Therapeutics USD -29.52M 32.4M 2024-09
Exelixis USD 579.18M 30.39M 2025-09
Gilead Sciences USD 6.2B 620M 2025-09
GlaxoSmithKline GBP 6.18B 106M 2025-12
Grifols EUR 766.49M 39.74M 2024-12
Halozyme Therapeutics USD 281.77M 2.41M 2025-09
Incyte USD 1.39B 118.68M 2025-12
Ionis Pharmaceuticals USD 155M 293M 2025-09
Ironwood Pharmaceuticals USD 85.24M 44.1M 2025-06
Karyopharm Therapeutics USD -30.78M 1.29M 2024-12
MacroGenics USD 61.25M 88.71M 2025-09
Merck USD 13.42B 431M 2025-09
Nektar Therapeutics USD 13.75M 650K 2024-06
Neurocrine Biosciences USD 780.9M 104.7M 2025-09
Novartis USD 10.82B 695M 2025-09
Pfizer USD 3.54B 7.61B 2025-09
Roche Holding CHF 22.09B 10.04B 2025-12
Sarepta Therapeutics USD 247.9M 209.96M 2025-09
Takeda JPY 790.55B 262.97B 2025-12
Teva Pharmaceutical Industries USD 2.66B 351M 2025-12
Xencor USD 21M 22.61M 2025-09


Nektar Therapeutics Zysk Brutto Na Sprzedaży - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.